(Q39974625)

16 September 2017

Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model (English)

1 reference

16 September 2017

angiogenesis inhibitor

1 reference

F Solly

1

1 reference

16 September 2017

R Fish

2

1 reference

16 September 2017

B Simard

3

1 reference

16 September 2017

N Bolle

4

1 reference

16 September 2017

E Kruithof

5

1 reference

16 September 2017

B Polack

6

1 reference

16 September 2017

G Pernod

7

1 reference

16 September 2017

6 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

15

1 reference

16 September 2017

685-692

1 reference

16 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2008.36

16 September 2017

0 references

cites work

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

What the structure of angiostatin may tell us about its mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesna

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

High tPA-expression in primary melanoma of the limb correlates with good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Differentiated rat glial cell strain in tissue culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

A study of proteases and protease-inhibitor complexes in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Antiangiogenic cancer therapy with microencapsulated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

New non-angiogenesis dependent pathways for tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Molecular determinants of ovarian cancer plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

More on: on the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

Generation of Angiostatin by Reduction and Proteolysis of Plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

7 January 2021

In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

7 January 2021

Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

7 January 2021

Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

7 January 2021

Increasing lentiviral vector titer using inhibitors of protein kinase R.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.36

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.36

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference